Cytogenin

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameCytogenin

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMacrophage colony stimulating factor 2 stimulantsInterleukin-1 alpha stimulantsAngiogenesis inhibitors +[5]

TargetsMacrophage colony stimulating factor 2Interferon gammaInterleukin-1 alpha

Therapy Area/IndicationsArthritis, RheumatoidNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMercian Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMercian Corp

Active IndicationsN/A

Inactive IndicationsArthritis, RheumatoidNeoplasms

ATC CodeN/A